Eric Halioua

Eric Halioua is a renowned serial entrepreneur with a diverse background in biotechnology, healthcare, and life sciences.

He has a proven track record of successfully bringing four drug candidates from research to clinical trials, showcasing his exceptional strategic, technological, and managerial skills.

With over €130 million raised from various investors globally, Eric has an extensive network within the biotechnology industry.

Currently serving as the President and CEO of PDC*line Pharma, Eric is also actively involved in other biotech companies and strategic advisory boards.

His involvement extends to co-founding companies like Myosix, Murigenetics, Digital-Orthopaedics, and HairClone, each contributing to innovative solutions in tissue engineering, genetic disorders, digital health, and hair treatments.

In addition to his entrepreneurial ventures, Eric has held key positions in organizations such as Promethera Biosciences, Arthur D. Little, and IsoHealthcare Group, where he showcased his expertise in M&A, technology, and innovation management.

Eric's educational background in Molecular Biology, Pharmacology, and Management has equipped him with a unique skill set that blends scientific knowledge with business acumen.

A former CEO, board member, and strategic advisor, Eric Halioua continues to make significant contributions to the biopharmaceutical and biotechnology sectors.